Zobrazeno 1 - 6
of 6
pro vyhledávání: '"G-Andre Banat"'
Autor:
G-Andre Banat, Aleksandra Tretyn, Soni Savai Pullamsetti, Jochen Wilhelm, Andreas Weigert, Catherine Olesch, Katharina Ebel, Thorsten Stiewe, Friedrich Grimminger, Werner Seeger, Ludger Fink, Rajkumar Savai
Publikováno v:
PLoS ONE, Vol 10, Iss 9, p e0139073 (2015)
Recent studies indicate that the abnormal microenvironment of tumors may play a critical role in carcinogenesis, including lung cancer. We comprehensively assessed the number of stromal cells, especially immune/inflammatory cells, in lung cancer and
Externí odkaz:
https://doaj.org/article/1c3b10634286491f8fda4890613bf45c
Autor:
Wolfgang George, G.-Andre Banat
Publikováno v:
Deutsche Zeitschrift für Onkologie. 47:1-3
Autor:
Marianne Hoeck, Nurguel Usluoglu, Hans Pralle, G.-Andre Banat, Kerstin Ihlow, Sabine Hoppmann
Publikováno v:
British Journal of Haematology. 126:593-601
Summary Several reports have described various strategies of dendritic cell (DC) vaccination to induce specific T-cell responses in patients with acute myeloid leukaemia (AML). About 50–60% of AML cases blasts have chromosomal abnormalities, such a
Autor:
Mathias J, Rummel, Norbert, Niederle, Georg, Maschmeyer, G Andre, Banat, Ulrich, von Grünhagen, Christoph, Losem, Dorothea, Kofahl-Krause, Gerhard, Heil, Manfred, Welslau, Christina, Balser, Ulrich, Kaiser, Eckhart, Weidmann, Heinz, Dürk, Harald, Ballo, Martina, Stauch, Fritz, Roller, Juergen, Barth, Dieter, Hoelzer, Axel, Hinke, Wolfram, Brugger, J, Zimber
Publikováno v:
Lancet (London, England). 381(9873)
Rituximab plus chemotherapy, most often CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), is the first-line standard of care for patients with advanced indolent lymphoma, and for elderly patients with mantle-cell lymphoma. Bendamusti
Autor:
G-Andre, Banat, Nurguel, Usluoglu, Marianne, Hoeck, Kerstin, Ihlow, Sabine, Hoppmann, Hans, Pralle
Publikováno v:
British journal of haematology. 126(4)
Several reports have described various strategies of dendritic cell (DC) vaccination to induce specific T-cell responses in patients with acute myeloid leukaemia (AML). About 50-60% of AML cases blasts have chromosomal abnormalities, such as inv(16)
Autor:
Norbert Niederle, Heinz A. Duerk, Martina Stauch, Christina Balser, Axel Hinke, Chrisoph Losem, G.-Andre Banat, Mathias J. Rummel, Manfred Welslau, Ulrich von Grünhagen, Harald Ballo, Wolfram Brugger, Eckhart Weidmann, Juergen Barth, Dorothea Kofahl-Krause, Fritz Roller, Gerhard Heil, Alexander Burchardt, Georg Maschmeyer, Ulrich Kaiser
Publikováno v:
Blood. 120:2724-2724
Abstract 2724 Background: The NHL 1 study, a prospective, multicenter, randomized, phase 3 study which compared B-R and CHOP-R as first-line treatment in indolent lymphomas and mantle cell lymphoma (MCL), demonstrated a significant benefit in progres